| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Microbiology, Mount Sinai School of Medicine, New York, New York 10029-6574
SSeCKS (pronounced essex) encodes a major protein kinase C substrate, the expression of which is down-regulated in src- and ras-trans-formed rodent fibroblasts but not in raf-transformed rodent fibroblasts (X. Lin et al., Mol. Cell. Biol., 15: 27542762, 1995). Using a panel of ras-transformed or revertant Rat-6 cells that exhibit selective parameters of transformation, we show that down-regulation of SSeCKS correlates with anchorage-independent growth. Cotransfection of NIH3T3 fibro-blasts with an SSeCKS expression plasmid decreased 630-fold the ability of a v-src expressor plasmid to induce colonies in soft agar. To differentiate between possible tumor suppressive or growth-inhibitory effects of SSeCKS, we developed conditionally transformed cell lines (expressing ts72v-src) with tetracycline-regulated SSeCKS expression. SSeCKS suppressed the ability of v-src to induce increased cellular refractility, focus formation, soft agar colony formation, in vitro invasiveness in Matrigel, and growth in low serum (0.5%) but did not inhibit cell proliferation in high serum (10%) at the permissive (35°C) temperature for src kinase activity. However, at the nonpermissive (39.5°C) temperature, SSeCKS induced growth arrest. SSeCKS expression did not affect: (a) the protein level, in vivo or in vitro kinase activity of ts72src; (b) the activity of jun NH2-terminal kinase; and (c) the level of mitogen-activated protein kinase (extracellular signal-regulated kinase 2) protein. However, extracellular signal-regulated kinase 2 activity was induced 510-fold by SSeCKS in the presence of active src. SSeCKS reversed the ability of v-src to decrease the formation of vinculin-associated adhesion plaques, actin-based stress fibers, and filopodia structures. These data suggest a tumor suppressive role for SSeCKS via the control of cytoskeletal architecture and cell signaling.
1 This work was supported by NIH Grant CA65787 (to I. H. G.).
2 To whom requests for reprints should be addressed, at Department of Microbiology, Box 1124, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029-6574. Phone: (212) 241-3749; Fax: (212) 534-1684; E-mail: igelman@smtplink.mssm.edu.
Received 11/26/96. Accepted 4/ 3/97.
This article has been cited by other articles:
![]() |
S. Akakura, C. Huang, P. J. Nelson, B. Foster, and I. H. Gelman Loss of the ssecks/gravin/akap12 Gene Results in Prostatic Hyperplasia Cancer Res., July 1, 2008; 68(13): 5096 - 5103. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Bu and I. H. Gelman v-Src-mediated Down-regulation of SSeCKS Metastasis Suppressor Gene Promoter by the Recruitment of HDAC1 into a USF1-Sp1-Sp3 Complex J. Biol. Chem., September 14, 2007; 282(37): 26725 - 26739. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. C. Weiser, U. J. Pyati, and D. Kimelman Gravin regulates mesodermal cell behavior changes required for axis elongation during zebrafish gastrulation Genes & Dev., June 15, 2007; 21(12): 1559 - 1571. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Su, Q. Zheng, M. M. Vaughan, Y. Bu, and I. H. Gelman SSeCKS Metastasis-Suppressing Activity in MatLyLu Prostate Cancer Cells Correlates with Vascular Endothelial Growth Factor Inhibition Cancer Res., June 1, 2006; 66(11): 5599 - 5607. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. H. Gelman and L. Gao SSeCKS/Gravin/AKAP12 Metastasis Suppressor Inhibits Podosome Formation via RhoA- and Cdc42-Dependent Pathways Mol. Cancer Res., March 1, 2006; 4(3): 151 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Streb, C. M. Kitchen, I. H. Gelman, and J. M. Miano Multiple Promoters Direct Expression of Three AKAP12 Isoforms with Distinct Subcellular and Tissue Distribution Profiles J. Biol. Chem., December 31, 2004; 279(53): 56014 - 56023. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Moissoglu and I. H. Gelman v-Src Rescues Actin-based Cytoskeletal Architecture and Cell Motility and Induces Enhanced Anchorage Independence during Oncogenic Transformation of Focal Adhesion Kinase-null Fibroblasts J. Biol. Chem., November 28, 2003; 278(48): 47946 - 47959. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xia, P. Unger, L. Miller, J. Nelson, and I. H. Gelman The Src-suppressed C Kinase Substrate, SSeCKS, Is a Potential Metastasis Inhibitor in Prostate Cancer Cancer Res., July 1, 2001; 61(14): 5644 - 5651. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Lin, P. Nelson, and I. H. Gelman SSeCKS, a Major Protein Kinase C Substrate with Tumor Suppressor Activity, Regulates G1right-arrowS Progression by Controlling the Expression and Cellular Compartmentalization of Cyclin D Mol. Cell. Biol., October 1, 2000; 20(19): 7259 - 7272. [Abstract] [Full Text] |
||||
![]() |
P. Nelson, K Moissoglu, J Vargas, P. Klotman, and I. Gelman Involvement of the protein kinase C substrate, SSeCKS, in the actin-based stellate morphology of mesangial cells J. Cell Sci., January 2, 1999; 112(3): 361 - 370. [Abstract] [PDF] |
||||
![]() |
C. Chapline, J. Cottom, H. Tobin, J. Hulmes, J. Crabb, and S. Jaken A Major, Transformation-sensitive PKC-binding Protein Is Also a PKC Substrate Involved in Cytoskeletal Remodeling J. Biol. Chem., July 31, 1998; 273(31): 19482 - 19489. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |